Pulmonary · PANCE / PANRE

Pneumoconioses (Silicosis, Asbestosis, Coal Worker's, Berylliosis)

Occupational interstitial lung diseases from inhaled inorganic dusts.

Also known as: silicosis, asbestosis, coal worker's pneumoconiosis, CWP, black lung, berylliosis, pneumoconiosis

Overview

Group of interstitial lung diseases caused by chronic inhalation of inorganic mineral dusts in occupational settings. Major forms: silicosis (silica), asbestosis (asbestos fibers), coal worker's pneumoconiosis (coal dust), and chronic beryllium disease (beryllium — granulomatous, sarcoid-like).

Epidemiology

Resurgence of accelerated silicosis among young engineered stone (quartz) countertop workers in US/Australia. Asbestosis declining due to bans but legacy exposures persist. CWP persists in coal mining regions globally. Berylliosis in aerospace, electronics, ceramics workers.

Try two board-style Pneumoconioses questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1PulmonaryMedium
A 40-year-old sandblaster with 20 years of exposure has progressive dyspnea, upper lobe nodular opacities with eggshell calcification of mediastinal lymph nodes on CT, and restrictive pulmonary function tests (PFTs). Which of the following is the most important ongoing surveillance for this patient?
  • APeriodic serum BNP
  • BSerial calcium and angiotensin-converting enzyme (ACE) levels
  • CAnnual spirometry
  • DTuberculosis screening
Reveal answer & full explanation
Correct answer: D — Tuberculosis screening
  • APeriodic serum BNP
  • BSerial calcium and angiotensin-converting enzyme (ACE) levels
  • CAnnual spirometry
  • DTuberculosis screening

Why Tuberculosis screening is correct

  • Silicosis directly impairs macrophage function, producing a roughly 3-fold increased risk of tuberculosis (TB) reactivation
  • Annual interferon-gamma release assay (IGRA) or tuberculin skin test (TST) plus chest CT every 1-2 years is the recommended surveillance protocol
  • TB screening is the single most critical ongoing monitoring measure in patients with silicosis

Why the others are wrong

  • Periodic serum BNP — monitors heart failure; not a standard surveillance measure for silicosis complications (confused-with cardiac disease)
  • Serial calcium and angiotensin-converting enzyme (ACE) levels — used to track sarcoidosis activity, not silicosis (confused-with sarcoidosis)
  • Annual spirometry — pulmonary function monitoring is part of silicosis follow-up but is not the single most important surveillance measure; TB screening takes priority (right-concept-wrong-priority)

Additional high-yield points

  • Silicosis is caused by crystalline silica inhalation from sandblasting, mining, quarrying, and tunneling
  • Eggshell calcification of hilar and mediastinal lymph nodes is characteristic of silicosis (also seen in sarcoidosis)
  • PFTs show a restrictive pattern, sometimes with an obstructive component; DLCO is reduced
  • No curative treatment exists; remove from silica exposure immediately
  • Lung transplant is reserved for end-stage disease
Question 2PulmonaryEasy
A 42-year-old man who works in construction presents with progressive dyspnea and a dry cough over 5 years. He denies smoking. CXR shows bilateral upper lobe nodular opacities with eggshell calcification of hilar lymph nodes. Pulmonary function tests (PFTs) show a mixed obstructive and restrictive pattern. What is the most likely diagnosis?
  • ASilicosis
  • BBerylliosis
  • CAsbestosis
  • DCoal worker's pneumoconiosis
Reveal answer & full explanation
Correct answer: A — Silicosis
  • ASilicosis
  • BBerylliosis
  • CAsbestosis
  • DCoal worker's pneumoconiosis

Why Silicosis is correct

  • Silicosis is caused by inhalation of crystalline silica dust from occupations such as construction, mining, sandblasting, and quarrying
  • Classic CXR findings: bilateral upper lobe nodular opacities with eggshell calcification of hilar lymph nodes, which is pathognomonic for silicosis
  • Progressive massive fibrosis can occur
  • Complications include increased risk of tuberculosis (TB) (silicotuberculosis) and lung cancer

Why the others are wrong

  • B) Berylliosis — berylliosis is rare and resembles sarcoidosis; it does not produce eggshell calcification of hilar nodes
  • C) Asbestosis — asbestosis causes bilateral lower lobe interstitial fibrosis with pleural plaques, not upper lobe nodules or eggshell calcification
  • D) Coal worker's pneumoconiosis — coal worker's pneumoconiosis lacks eggshell calcification of hilar lymph nodes
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Pneumoconioses (Silicosis, Asbestosis, Coal Worker's, Berylliosis) outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Silicosis: mining, quarrying, sandblasting, foundry work, engineered stone (quartz) countertop fabrication, ceramics, glass manufacture
  • Asbestosis: shipbuilding, construction (insulation, roofing), automotive brake/clutch work, asbestos mining (legacy exposures dominate)
  • Coal worker's pneumoconiosis: underground coal mining (cumulative exposure)
  • Berylliosis: aerospace, nuclear, electronics, ceramic and dental laboratory work
  • Cumulative exposure duration and intensity drive risk; smoking synergistic for malignancy

Pathophysiology

Inhaled mineral particles reach alveoli; alveolar macrophages phagocytose but cannot digest them → chronic inflammation, fibrogenic cytokine release (TGF-beta, TNF-alpha), fibroblast proliferation, collagen deposition. Silica is the most cytotoxic and fibrogenic. Asbestos fibers (amphiboles especially) cause pleural plaques, fibrosis, and malignancy. Beryllium triggers a delayed-type hypersensitivity (CD4 T-cell) granulomatous response indistinguishable histologically from sarcoidosis.

Clinical presentation

Symptoms

  • Progressive exertional dyspnea (most common across all forms)
  • Cough — often non-productive; productive with chronic bronchitis in CWP
  • Chest discomfort
  • Constitutional symptoms in advanced disease
  • Asbestos: long latency (20-40 years from first exposure)
  • Acute silicosis: rapidly progressive dyspnea after heavy short-term exposure (engineered stone, sandblasting)

Signs / physical exam

  • Bibasilar Velcro crackles (asbestosis, advanced silicosis)
  • Clubbing (asbestosis > silicosis)
  • Findings of cor pulmonale in advanced disease
  • Pleural plaques on imaging suggest asbestos exposure

Classic findings

Silicosis: upper-lobe nodules with hilar 'eggshell' calcifications. Asbestosis: lower-lobe fibrosis + pleural plaques (often calcified). CWP: small upper-lobe rounded opacities, may progress to progressive massive fibrosis. Berylliosis: indistinguishable from sarcoidosis.

Differential diagnosis

  • Idiopathic pulmonary fibrosis — No occupational exposure history; UIP pattern; older male smokers
  • Sarcoidosis — Granulomatous disease without beryllium exposure; mediastinal lymphadenopathy; non-caseating granulomas
  • Tuberculosis — Silicosis predisposes — silicotuberculosis; always exclude with sputum AFB/IGRA
  • Hypersensitivity pneumonitis — Organic dust exposure (birds, mold), upper-lobe centrilobular nodules, lymphocytic BAL
  • Connective tissue disease-ILD — Autoimmune features; positive serologies (ANA, RF, anti-CCP)
  • Lung cancer / mesothelioma (asbestos) — Mass lesion, pleural thickening with rind; biopsy diagnostic

Diagnostic workup

Labs

  • Detailed occupational history is essential
  • Beryllium lymphocyte proliferation test (BeLPT) — definitive for chronic beryllium disease
  • QuantiFERON / PPD in silicosis (increased TB risk — silicotuberculosis)
  • Sarcoid workup if granulomatous: ACE, calcium, exclude alternatives

Imaging

  • CXR: simple silicosis — upper-lobe small (<10 mm) rounded opacities; complicated silicosis — progressive massive fibrosis (>10 mm conglomerate masses); eggshell calcification of hilar nodes
  • Asbestosis: lower-lobe reticular/honeycomb fibrosis + pleural plaques (often calcified diaphragmatic), shaggy heart border
  • CWP: small rounded opacities upper lobes, similar to silicosis but without eggshell calcifications
  • HRCT: characterize fibrosis distribution, nodule pattern, pleural disease, exclude malignancy
  • PFTs: restrictive pattern with reduced DLCO; obstructive component in CWP with chronic bronchitis

Other studies

  • Bronchoscopy with biopsy if diagnosis uncertain or malignancy suspected
  • BeLPT (blood or BAL) for chronic beryllium disease
  • Lung biopsy rarely needed when occupational exposure + classic imaging are present

Diagnostic algorithm

PneumoconiosisExposureCXR PatternDistinctive Features
SilicosisQuartz dust (mining, sandblasting, engineered stone)Upper-lobe small nodules; eggshell hilar node calcification; PMFTB risk; autoimmune associations; accelerated form in engineered stone workers
AsbestosisAsbestos fibers (construction, shipbuilding)Lower-lobe reticular fibrosis; pleural plaquesLong latency (20-40 yr); risk of mesothelioma and lung cancer (synergy with smoking)
Coal Worker's PneumoconiosisCoal dust (mining)Upper-lobe small rounded opacities; PMF in complicated diseaseBlack lung; Caplan syndrome with RA
Chronic Beryllium DiseaseBeryllium dust (aerospace, electronics, ceramics)Mimics sarcoidosis — hilar adenopathy + granulomasBeLPT diagnostic; treat with steroids like sarcoid
Comparison of the four major pneumoconioses — exposure, radiographic pattern, and distinguishing features.

Treatment

First-line

  • No specific cure for any pneumoconiosis — supportive care is the mainstay
  • Remove from further exposure (legally protected occupational right)
  • Smoking cessation — especially critical in asbestos exposure (synergistic lung cancer risk; ~50× in smokers with asbestos vs ~5× alone)
  • Vaccinations: annual influenza, pneumococcal, COVID-19, RSV (age ≥60), Tdap
  • Pulmonary rehabilitation, supplemental oxygen for hypoxemia
  • Treat comorbid airflow obstruction (bronchodilators, ICS) in CWP
  • Annual TB screening (IGRA) in silicosis; treat LTBI; consider 4-drug therapy if active
  • Chronic beryllium disease — corticosteroids (prednisone 20-40 mg/day) for symptomatic disease, similar to sarcoidosis

Second-line / adjunct

  • Lung transplantation for end-stage disease in select patients
  • Surveillance for malignancy in asbestos-exposed: low-dose CT screening, especially with concomitant smoking; awareness for mesothelioma (insidious chest pain, pleural effusion, pleural thickening)
  • Whole-lung lavage for severe acute silicosis (anecdotal, specialized centers)
  • Antifibrotic therapy (pirfenidone, nintedanib) — emerging role for progressive pulmonary fibrosis phenotype, including occupational ILDs (PF-ILD)
  • Workers' compensation and occupational disease reporting

Complications

  • Progressive massive fibrosis (silicosis, CWP)
  • Tuberculosis and atypical mycobacterial infection (especially silicosis)
  • Lung cancer (all pneumoconioses, multiplied by smoking)
  • Mesothelioma (asbestos — even brief exposure; latency 20-40 years)
  • Pulmonary hypertension, cor pulmonale, respiratory failure
  • Caplan syndrome (rheumatoid pneumoconiosis with large necrotic nodules)
  • Autoimmune disease (silicosis — increased scleroderma, RA, SLE)

PANCE pearls

  • Engineered stone (quartz) countertops have caused a global epidemic of accelerated silicosis in young workers — high silica content + dry cutting.
  • Eggshell calcification of hilar lymph nodes is the classic silicosis finding.
  • Pleural plaques (often calcified diaphragmatic) are pathognomonic for asbestos exposure but do not require asbestosis; mesothelioma can occur without asbestosis.
  • Silicosis dramatically increases TB risk — screen annually with IGRA; consider isoniazid prophylaxis even with intermediate risk.
  • Chronic beryllium disease mimics sarcoidosis histologically — BeLPT testing distinguishes; ask about aerospace, electronics, ceramic dust exposure.

References

  • ATS 2010 — ATS Statement on Occupational Contribution to the Burden of Airway Disease (Am J Respir Crit Care Med 2003)
  • MMWR 2019 — Severe Silicosis in Engineered Stone Fabrication Workers — California, Colorado, Texas, and Washington, 2017-2019 (Rose et al., MMWR 2019)
  • Helsinki Criteria 2014 — Asbestos, Asbestosis, and Cancer — Helsinki Criteria for Diagnosis and Attribution 2014 (Wolff et al., Scand J Work Environ Health 2016)
  • ATS 2014 — Chronic Beryllium Disease — ATS Official Statement (Balmes et al., Am J Respir Crit Care Med 2014)

Practice Pulmonary questions on FirstPassPA

Turn this outline into retention. 6,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Answer the 2 free questions above → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.